Best of the 11th Annual Cardiometabolic Health Congress (Expired): Virtual Highlights
Health care providers play a major role in stemming the future burden of cardiovascular disease, diabetes, and associated comorbidities by employing strategies for the early identification and comprehensive management of patients presenting with multiple cardiometabolic risk factors. The Best of 11th Annual CMHC Virtual Highlights will provide an opportunity for busy clinicians to catch up on the latest developments in cardiovascular health through a convenient series of 4 expert interviews and transcripts from the 2016 annual meeting
Best of the 11th Annual Cardiometabolic Health Congress (Expired): Virtual Highlights
Activity Title: Best of the 11th Annual Cardiometabolic Health Congress: Virtual Highlights
Activity Format: Virtual Highlights
Health care providers play a major role in stemming the future burden of cardiovascular disease, diabetes, and associated comorbidities by employing strategies for the early identification and comprehensive management of patients presenting with multiple cardiometabolic risk factors. The Best of 11th Annual CMHC Virtual Highlights will provide an opportunity for busy clinicians to catch up on the latest developments in cardiovascular health through a convenient series of 4 expert interviews and transcripts from the 2016 annual meeting.
Estimated Time to Complete: 1.5 Hours
Release Date: December 30, 2016
Expiration Date: December 30, 2017
Credit Type(s) Available: ACCME, CDR, ANCC
Maximum Credits: 1.5 AMA PRA Category 1 Credit(s)TM
Provided By: This activity is jointly provided by Medical Education Resources, Inc (MER) and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.
This educational activity is multi-supported through educational grants from Amgen, Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC., and Pfizer.
To improve patient outcomes through early identification and intervention strategies for patients with, or at risk of developing, diabetes and cardiovascular disease.
This activity is designed for advanced-level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk.
Upon completion of this activity, participants should be able to:
Module 1 Learning Objectives: Update on Lipid Modifying Therapies
Determine optimal LDL-C target goals in high-risk individuals, including those with residual ASCVD risk such as familial hypercholesterolemia, diabetic dyslipidemia and/or statin intolerance in light of current consensus recommendations.
Review the latest clinical trial data and physiologic rationale for the new drug classes, practicalities of their administration, including potential for use as replacement or complementary treatment for patients on a statin, patient selection for use of these drugs, as well as the need for additional outcomes studies.
Module 2 Learning Objectives: Evolving Landscape in the Management of Heart Failure
Identify patients with cardiometabolic disease who are at risk for HF.
Implement the 2013 ACCF/AHA guidelines for the pharmacologic management of patients with HFrEF in clinical practice.
Recommend optimal treatment regimens for patients with HFrEF based on the safety and efficacy of current and recently FDA-approved HF therapies.
Module 3 Learning Objectives: Update on CV Outcome Trials and Diabetes
Discuss results of clinical outcome studies in persons with diabetes that support the benefits of glycemic control versus extra-glycemic effects that may produce a reduction in cardiometabolic risk.
Integrate into clinical practice individualized approaches for effectively improving outcomes in persons with T2DM.
Develop clinical strategies for the timely initiation and intensification of insulin therapy.
Appraise data on new and emerging insulin formulations, including safety, efficacy, effects on hypoglycemia and nocturnal hypoglycemia, and pharmacological profiles.
Describe how to integrate novel insulin therapies and combinations into clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase acceptance and adherence for patients.
Robert H. Eckel, MD (Chairperson)
Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
Division of Cardiology
Professor of Physiology and Biophysics
Charles A. Boettcher II Chair in Atherosclerosis
Director, T32 in Obesity and Cardiovascular Disease
It is the policy of MER to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The following content managers reported no financial relationships with commercial interests whose products or services may be mentioned in this CME/CE activity:
MER: Julie Johnson, PharmD, Veronda Smith, FNP
CMHC: Erin Franceschini, MS, Mary Mihalovic, Karin McAdams
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources and Tarsus Cardio Inc. dba Cardiometabolic Health Congress. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.
Medical Education Resources designates each enduring material for a maximum of 1.5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Each CE activity provides 1.5 contact hour of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hour.
Medical Education Resources (Provider Number ME110) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education units (CPEUs) for completion of each program/material.
(CDR Activity Number: 130869)
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER, CMHC and/or the various industry supporters. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, CMHC, and/or the various industry supporters. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Participants are expected to answer all delivered questions before attempting to complete the post-test and evaluation for that activity. Successful completion will lead to the issuance of a certificate for 1.5 AMA PRA Category 1 Credit(s)™.
To receive credit, the course must be completed on or before December 30, 2017.
There are no fees for participating in and receiving CME credit for this activity. In order to claim CME credit for this activity registration is required prior to viewing the activity.
During the period December 30, 2016 through December 30, 2017, participants must follow these steps in order to receive CME/CE credit:
Sign In or Register at https://www.cardiometabolichealth.org/my-account.html
Read and accept the Terms & Conditions including the learning objectives and faculty disclosures.
Complete the pre-test by recording the best answer to each question in the answer key. There is no scoring of the pre-test questions section.
Review the educational activity.
Complete the post-test by recording the best answer to each question in the answer key. Successful completion of the post-test is required to earn CME/CE credit. Successful completion is defined as a cumulative score of at least 70%.
Complete the online evaluation form.
After successfully completing the post-test and online evaluation form, your CME/CE certificate will be generated and will be available immediately for print.
Hardware and Software Requirements:
This online activity must be viewed with the latest version of Chrome, Firefox or Internet Explorer. If you do not have these browsers, you can download Chrome here, Firefox here and Internet Explorer here. Optimal viewing requires a broadband connection of at least 3 Mbps and a 1 GHz processor with 1 GB RAM.
Policy on Privacy and Confidentiality:
MER can be contacted by e-mail at firstname.lastname@example.org or by telephone at 303-798-9682.
Please check the agreement box before continuing.
I have read the information above and agree to continue with this program.